2015 American Transplant Congress
Assessment of Actual Pediatric Organ Donation Potential: Neurologic and Circulatory Determination of Death at a Children's Hospital
BACKGROUND AND OBJECTIVES: Organ donation after circulatory determination of death (DCDD) is increasing. DCDD offers potential for additional abdominal organ donation. We evaluated all dying…2015 American Transplant Congress
An Orchestrated Sequence of Innate and Adaptive Immune Responses Is Associated With Rejection After Pediatric Liver Transplantation
The concept of a coordinated immune response initiated by innate and sustained by adaptive immune cells and their soluble mediators is well established for infection…2015 American Transplant Congress
High Incidence of Masked Hypertension in Pediatric Recipients of Stem Cell Transplantation
Purpose: Different from recipients of a solid organ transplant, stem cell transplantation (SCT) recipients do not receive long term immunosuppressive treatment that may cause renal…2015 American Transplant Congress
Standardizing Quality Improvement Practices in Pediatric Liver Transplantation: The SPLIT A3 Project
Quality improvement (QI) programs are key drivers of continual reform in process and patient safety, but at present, there are no pediatric liver transplant (PLT)-specific…2015 American Transplant Congress
The Use of Inhaled Tobramycin in Pediatric Transplant Patients Without Cystic Fibrosis
Purpose:To evaluate dosing strategies used and systemic levels achieved of inhaled tobramycin in pediatric patients without cystic fibrosis (CF)Methods:A retrospective single-center chart review was performed…2015 American Transplant Congress
Does Higher Cost Improve Outcome in Pediatric Liver Transplantation?
Surgery, Boston Children's Hospital, Boston, MA.
Examine the relationship between transplant-related total cost and 1-year graft failure and patient mortality rate for liver transplantation at freestanding children's hospitals.Using the Pediatric Health…2015 American Transplant Congress
Arterial Hypertension and the Use of Antihypertensive Medication in Pediatric Renal Transplant Patients: An Analysis of the CERTAIN Registry
BackgroundOur study aimed to describe the prevalence of hypertension, blood pressure (BP) control and the use of antihypertensive (AH) drugs in pediatric renal transplant patients.MethodsCasual…2015 American Transplant Congress
Broader Geographic Sharing of Adolescent Lung Donors Improves Allocation Efficiency
Allocating pediatric donor lungs to pediatric lung transplant (TXP) candidates results in better graft function. However, 87% of adolescent (ADL) donor lungs are allocated to…2015 American Transplant Congress
Gene Expression Monitoring in Pediatric Heart Transplant Recipients
Allomap® gene expression testing is a non-invasive screening tool approved for use in heart transplant recipients age 15 and older. Experience with Allomap® in pediatric…2015 American Transplant Congress
Suboptimal Vaccination Coverage After Liver Transplantation: Opportunity for Improvement
Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Elimination of vaccine-preventable disease after solid organ transplantation (SOT) has the potential to improve outcomes. We evaluated immunization rates and the impact of directed recommendations…
American Transplant Congress abstracts